JP6918827B2 - 新規なn−[(ピリジルオキシ)プロパニル]ベンズアミド - Google Patents

新規なn−[(ピリジルオキシ)プロパニル]ベンズアミド Download PDF

Info

Publication number
JP6918827B2
JP6918827B2 JP2018554080A JP2018554080A JP6918827B2 JP 6918827 B2 JP6918827 B2 JP 6918827B2 JP 2018554080 A JP2018554080 A JP 2018554080A JP 2018554080 A JP2018554080 A JP 2018554080A JP 6918827 B2 JP6918827 B2 JP 6918827B2
Authority
JP
Japan
Prior art keywords
mmol
mixture
hplc
esi
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018554080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019511548A5 (enExample
JP2019511548A (ja
Inventor
ドリス リーター
ドリス リーター
マルコ フェッラーラ
マルコ フェッラーラ
ニクラス ハイネ
ニクラス ハイネ
ウータ レッセル
ウータ レッセル
ジャネット レイチェル ニコルソン
ジャネット レイチェル ニコルソン
アントン ペクセック
アントン ペクセック
Original Assignee
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング, ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2019511548A publication Critical patent/JP2019511548A/ja
Publication of JP2019511548A5 publication Critical patent/JP2019511548A5/ja
Application granted granted Critical
Publication of JP6918827B2 publication Critical patent/JP6918827B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2018554080A 2016-04-15 2017-04-07 新規なn−[(ピリジルオキシ)プロパニル]ベンズアミド Active JP6918827B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16165529 2016-04-15
EP16165529.5 2016-04-15
PCT/EP2017/058315 WO2017178340A1 (en) 2016-04-15 2017-04-07 Novel n-[(pyridyloxy)propanyl]benzamides

Publications (3)

Publication Number Publication Date
JP2019511548A JP2019511548A (ja) 2019-04-25
JP2019511548A5 JP2019511548A5 (enExample) 2021-05-20
JP6918827B2 true JP6918827B2 (ja) 2021-08-11

Family

ID=55755463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018554080A Active JP6918827B2 (ja) 2016-04-15 2017-04-07 新規なn−[(ピリジルオキシ)プロパニル]ベンズアミド

Country Status (4)

Country Link
US (1) US10787432B2 (enExample)
EP (1) EP3442958B1 (enExample)
JP (1) JP6918827B2 (enExample)
WO (1) WO2017178340A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6643501B2 (ja) * 2016-04-15 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なn−[(ピラジニルオキシ)プロパニル]ベンズアミド
WO2017178344A1 (en) 2016-04-15 2017-10-19 Boehringer Ingelheim International Gmbh Novel n-[(heteroaryloxy)propanyl]heteroaryl carboxamides
US10710984B2 (en) 2016-04-15 2020-07-14 Boehringer Ingelheim International Gmbh N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
JP6591698B2 (ja) * 2016-04-15 2019-10-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なn−[(ピリミジニルアミノ)プロパニル]−およびn−[(ピラジニルアミノ)プロパニル]アリールカルボキサミド
WO2017178340A1 (en) 2016-04-15 2017-10-19 Boehringer Ingelheim International Gmbh Novel n-[(pyridyloxy)propanyl]benzamides
WO2017178338A1 (en) 2016-04-15 2017-10-19 Boehringer Ingelheim International Gmbh Novel n-[(pyrimidinyloxy)propanyl]benzamides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130341D0 (en) 2001-12-19 2002-02-06 Smithkline Beecham Plc Compounds
WO2009011775A1 (en) 2007-07-13 2009-01-22 Merck & Co., Inc. Amidoethyl alkylamino orexin receptor antagonists
KR20150023390A (ko) 2012-06-15 2015-03-05 다이쇼 세이야꾸 가부시끼가이샤 분지쇄 알킬 헤테로 방향환 유도체
JP2016028017A (ja) 2012-12-13 2016-02-25 大正製薬株式会社 フッ素置換ピペリジン化合物
JP2017100950A (ja) 2014-04-04 2017-06-08 大正製薬株式会社 オキソ複素環誘導体
GB201415569D0 (en) * 2014-09-03 2014-10-15 C4X Discovery Ltd Therapeutic Compounds
JP6643501B2 (ja) * 2016-04-15 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なn−[(ピラジニルオキシ)プロパニル]ベンズアミド
WO2017178344A1 (en) 2016-04-15 2017-10-19 Boehringer Ingelheim International Gmbh Novel n-[(heteroaryloxy)propanyl]heteroaryl carboxamides
US10710984B2 (en) * 2016-04-15 2020-07-14 Boehringer Ingelheim International Gmbh N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
JP6591698B2 (ja) 2016-04-15 2019-10-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なn−[(ピリミジニルアミノ)プロパニル]−およびn−[(ピラジニルアミノ)プロパニル]アリールカルボキサミド
WO2017178340A1 (en) 2016-04-15 2017-10-19 Boehringer Ingelheim International Gmbh Novel n-[(pyridyloxy)propanyl]benzamides
WO2017178338A1 (en) 2016-04-15 2017-10-19 Boehringer Ingelheim International Gmbh Novel n-[(pyrimidinyloxy)propanyl]benzamides

Also Published As

Publication number Publication date
WO2017178340A1 (en) 2017-10-19
EP3442958B1 (en) 2020-05-06
US20190112291A1 (en) 2019-04-18
US10787432B2 (en) 2020-09-29
EP3442958A1 (en) 2019-02-20
JP2019511548A (ja) 2019-04-25

Similar Documents

Publication Publication Date Title
JP6918827B2 (ja) 新規なn−[(ピリジルオキシ)プロパニル]ベンズアミド
KR102633122B1 (ko) 브로모도메인에 대하여 활성을 갖는 화합물
JP6643502B2 (ja) 新規なn−[(ヘテロアリールオキシ)プロパニル]ヘテロアリールカルボキサミド
JP6577152B2 (ja) 新規なn−[(ピリミジニルオキシ)プロパニル]ベンズアミド
JP6591698B2 (ja) 新規なn−[(ピリミジニルアミノ)プロパニル]−およびn−[(ピラジニルアミノ)プロパニル]アリールカルボキサミド
JP6703131B2 (ja) 新規なn−[(ピリミジニルアミノ)プロパニル]−およびn−[(ピリジニルアミノ)プロパニル]アリールカルボキサミド
JP2013538227A (ja) ピリジン化合物およびその使用
CN101878199A (zh) 用于治疗例如高血脂或动脉硬化疾病的作为cetp抑制剂的1,2-二取代的-4-苄基氨基-吡咯烷衍生物
JP6643501B2 (ja) 新規なn−[(ピラジニルオキシ)プロパニル]ベンズアミド
JP6880325B2 (ja) 新規なn−[(ピリミジニルアミノ)プロパニル]−、n−[(ピリジルアミノ)プロパニル]−およびn−[(ピラジニルアミノ)プロパニル]アリールカルボキサミド
CN107602564B (zh) 布鲁顿酪氨酸激酶抑制剂
TW201936198A (zh) 咪唑并吡啶衍生物及其作為藥劑之用途
EP3442964B1 (en) Novel n-[(pyrimidinylamino)propanyl]-and n [(pyrazinylamino)propanyl]arylcarboxamides
GB2640329A (en) Hedgehog acyltransferase inhibitors
WO2025215121A1 (en) Hedgehog acyltransferase inhibitors
TW202430165A (zh) Il-17之小分子調節劑
EP3442966A1 (en) Noveln

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210331

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20210331

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210621

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210721

R150 Certificate of patent or registration of utility model

Ref document number: 6918827

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250